An investigation on behalf of investors in Genesis Healthcare Inc (NYSE:GEN) shares over potential wrongdoing at Genesis Healthcare was announced and NYSE:GEN stockholders should contact the Shareholders Foundation
San Diego, CA -- (SBWIRE) -- 05/27/2016 -- An investigation was announced for stockholders of of Genesis Healthcare Inc (NYSE:GEN) was announced over potential breaches of fiduciary duties by certain directors at Genesis Healthcare.
Investors who purchased shares of Genesis Healthcare Inc (NYSE:GEN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Genesis Healthcare officers and directors breached their fiduciary duties.
Genesis Healthcare Inc reported that its annual Total Revenue rose from over $4.76 billion in 2014 to over $5.61 billion in 2015 while its Net Loss increased from $239.94 million in 2014 to $424.98 million in 2015.
Shares of Genesis Healthcare Inc (NYSE:GEN) declined from as high as $9.22 per share in January 2015 to as low as $1.42 per share in February 2016.
On May 25, 2016, NYSE:GEN shares closed at $1.86 per share.
Those who purchased shares of Genesis Healthcare Inc have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com